首页> 外国专利> CONTRAST AGENT FOR NUCLEAR MAGNETIC RESONANCE IMAGING (MRI): A GLUCIDIC DERIVATIVE MARKED BY STABLE CARBON 13 ISOTOPES FOR THE IN VIVO STUDY OF NORMAL AND PATHOLOGICAL METABOLISM

CONTRAST AGENT FOR NUCLEAR MAGNETIC RESONANCE IMAGING (MRI): A GLUCIDIC DERIVATIVE MARKED BY STABLE CARBON 13 ISOTOPES FOR THE IN VIVO STUDY OF NORMAL AND PATHOLOGICAL METABOLISM

机译:核磁共振成像(MRI)的对比剂:以稳定的碳13同位素为标记的糖化衍生物,用于体内和正常代谢研究

摘要

The present invention relates to a fluoro-deoxyglucose, comprising at least one isotope of carbon 13, as a medicament for use in a method for the quantitative and / or qualitative diagnosis of conditions, diseases, pathologies, syndromes or disorders in the body of the body. a subject, said diagnostic method occurring in vivo using nuclear magnetic resonance, and said carbon isotope 13 not being directly connected to a deuterium. The present invention also relates to a composition, chemical formulation and / or galenic comprising at least one fluoro-deoxy-glucose according to the invention, and a kit comprising on the one hand any commercial manufactured form, galenic formulation favorable to any administration in a subject regardless of the route of administration, containing one or more fluoro-deoxy-glucoses according to the invention.
机译:氟脱氧葡萄糖技术领域本发明涉及一种氟脱氧葡萄糖,其包含至少一个碳13的同位素,作为一种药物,用于定量和/或定性诊断其身体状况,疾病,病理,综合症或疾病的方法。身体。受试者,所述诊断方法利用核磁共振在体内发生,并且所述碳同位素13不直接与氘连接。本发明还涉及包含至少一种根据本发明的氟代-脱氧-葡萄糖的组合物,化学制剂和/或盖伦制剂,以及一种试剂盒,该试剂盒一方面包含任何商业制造形式的盖伦制剂,其有利于以任何方式施用。受试者,无论给药途径如何,均含有一种或多种本发明的氟-脱氧葡萄糖。

著录项

  • 公开/公告号FR3066099A1

    专利类型

  • 公开/公告日2018-11-16

    原文格式PDF

  • 申请/专利权人 MICHEL HOEN;JULIEN DETOUR;

    申请/专利号FR20170070493

  • 发明设计人 MICHEL HOEN;JULIEN DETOUR;

    申请日2017-05-15

  • 分类号A61B5/055;A61K31/70;

  • 国家 FR

  • 入库时间 2022-08-21 11:43:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号